Coronavirus latest: Pfizer and FDA discuss clinical trial for boosters for Covid-19 variants
Pfizer says it is discussing a clinical trial for a booster for new Covid-19 variants with the Food and Drug Administration, after the US regulator urged vaccine makers to prepare to adapt their shots ...

The contents of this article including any associated images are © ft.com 2021